Importance of therapeutic monitoring of orally administered disease-modifying drugs used in the treatment of multiple sclerosis - TDM-MS

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2021
This article has no abstract
Epistemonikos ID: 2e4b32dd9555fcef66cc258654e531e8267a6e5c
First added on: Apr 17, 2025